Vaccine Delivery Devices Market
The latest market report published by Credence Research, Inc. is “Global Vaccine Delivery Devices Market: Growth, Future Prospects, and Competitive Analysis, 2016 – 2028”. The Global Vaccine Delivery Devices Market generated revenue of around USD 3.7 billion in 2021 and is anticipated to grow a CAGR of over 8.4% during the forecast period from 2022 to 2028 to reach around USD 6.0 billion in 2028. In contrast, the cumulative growth opportunity presented by the global vaccine delivery devices market is around USD 2.3 billion from 2022 to 2028.
Growing immunization programs and their expanding coverage, increased vaccination research, improved government support and investment, innovation of novel vaccines, and various initiatives and campaigns are key factors driving the market growth. Pharmaceutical and biotech companies collaborate with governments worldwide to develop a strategy for overcoming supply chain issues related to vaccine delivery. The need for a COVID-19 vaccine and the urgency of finding one has sparked interest in developing one or more efficient and secure viral delivery systems. Moreover, technological advancements in vaccine delivery are expected to drive market growth. However, the rising cost of micro-needles, particularly in developing countries, is a major factor impeding market growth.
The global vaccine delivery devices market is bifurcated into Product Type, Route of Administration, End User, and Geography. Based on product type, the market is categorized into syringes, jet injectors, microneedles, aerosol/dry powder inhalation, intranasal delivery devices, and intradermal delivery devices. Based on the route of administration, the global market is segmented into intradermal, intramuscular, subcutaneous, and others. Based on the end user, the market is divided into hospitals, clinics, and others. Geographically, the market is divided into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.
Access complete report with short-term and long-term impact of COVID-19 on this market. Please visit: https://www.credenceresearch.com/report/vaccine-delivery-device-market
In 2021, North America dominated the global vaccine delivery devices market and accounted for a major market revenue share. The high prevalence of infectious diseases, rising R&D expenditures for new vaccines, and expanding immunization coverage are major regional market expansion drivers. The large regional share of the market is also attributed to sophisticated healthcare infrastructure, high public and professional awareness, and sophisticated healthcare professionals.
Why to Buy This Report –
Table of Content
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Segmentation
2.1. Market Snapshot: Global Vaccine Delivery Devices Market
2.2. Global Vaccine Delivery Devices Market, By Component
2.3. Global Vaccine Delivery Devices Market, By Route of Administration
2.4. Global Vaccine Delivery Devices Market, By End User
2.5. Global Vaccine Delivery Devices Market, By Region
3.1. Introduction
3.1.1. Global Vaccine Delivery Devices Market Value, 2016-2028, (US$ Bn)
3.2. Market Dynamics
3.2.1. Key Growth Trends
3.2.2. Market Drivers
3.2.3. Market Restraints
3.2.4. Market Opportunities
3.2.5. Major Industry Challenges
3.3. Attractive Investment Proposition,2021
3.3.1. Product Type
3.3.2. Route of Administration
3.3.3. End User
3.3.4. Geography
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Value Chain Analysis
4.4. Technology Analysis
4.5. Marketing Strategy Analysis
4.5.1. Direct Marketing
4.5.2. Indirect Marketing
4.5.3. Marketing Channel Development Trend
5.1. Company market share of key players, 2021
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others
6.1. Global Vaccine Delivery Devices Market Pre Vs Post COVID 19, 2019 – 2028
6.2. Impact on Import & Export
6.3. Impact on Demand & Supply
7.1. Global Vaccine Delivery Devices Market, by Product Type, 2016-2028(US$ Bn)
7.1.1. Overview
7.1.2. Global Vaccine Delivery Devices Market, By Product Type, 2021 vs. 2028 (in%)
7.1.3. Global Vaccine Delivery Devices Market, By Syringes, 2016-2028 (US$ Bn)
7.1.4. Global Vaccine Delivery Devices Market, By Jet Injectors, 2016-2028 (US$ Bn)
7.1.5. Global Vaccine Delivery Devices Market, By Micro Needles, 2016-2028 (US$ Bn)
7.1.6. Global Vaccine Delivery Devices Market, By Aerosol/Dry Powder Inhalation, 2016-2028 (US$ Bn)
7.1.7. Global Vaccine Delivery Devices Market, By Intranasal Delivery Devices, 2016-2028 (US$ Bn)
7.1.8. Global Vaccine Delivery Devices Market, By Intradermal Delivery Devices, 2016-2028 (US$ Bn)
7.2. Global Vaccine Delivery Devices Market, by Route of Administration, 2016-2028(US$ Bn)
7.2.1. Overview
7.2.2. Global Vaccine Delivery Devices Market, By Intradermal, 2021 vs 2028 (in%)
7.2.3. Global Vaccine Delivery Devices Market, By Intramuscular, 2016-2028 (US$ Bn)
7.2.4. Global Vaccine Delivery Devices Market, By Subcutaneous, 2016-2028 (US$ Bn)
7.2.5. Global Vaccine Delivery Devices Market, By Others, 2016-2028 (US$ Bn)
7.3. Global Vaccine Delivery Devices Market, by End User, 2016-2028(US$ Bn)
7.3.1. Overview
7.3.2. Global Vaccine Delivery Devices Market, By End User, 2021 vs 2028 (in%)
7.3.3. Global Vaccine Delivery Devices Market, By Hospitals, 2016-2028 (US$ Bn)
7.3.4. Global Vaccine Delivery Devices Market, By Clinics, 2016-2028 (US$ Bn)
7.3.5. Global Vaccine Delivery Devices Market, By Others, 2016-2028 (US$ Bn)
8.1. North America Vaccine Delivery Devices Market, by Product Type, 2016-2028(US$ Bn)
8.1.1. Overview
8.1.2. SRC Analysis
8.2. North America Vaccine Delivery Devices Market, by Route of Administration, 2016-2028(US$ Bn)
8.2.1. Overview
8.2.2. SRC Analysis
8.3. North America Vaccine Delivery Devices Market, by End User, 2016-2028(US$ Bn)
8.3.1. Overview
8.3.2. SRC Analysis
8.4. North America Vaccine Delivery Devices Market, by Country, 2016-2028 (US$ Bn)
8.4.1. U.S.
8.4.1.1. U.S. Vaccine Delivery Devices Market Estimates and Forecast, 2016-2028 (US$ Bn)
8.4.1.2. U.S. Vaccine Delivery Devices, By Product Type, 2016-2028 (US$ Bn)
8.4.1.3. U.S. Vaccine Delivery Devices, By Route of Administration, 2016-2028 (US$ Bn)
8.4.1.4. U.S. Vaccine Delivery Devices, By End User, 2016-2028 (US$ Bn)
8.4.2. Canada
8.4.2.1. Canada Vaccine Delivery Devices Market Estimates and Forecast, 2016-2028 (US$ Bn)
8.4.2.2. Canada Vaccine Delivery Devices, By Product Type, 2016-2028 (US$ Bn)
8.4.2.3. Canada Vaccine Delivery Devices, By Route of Administration, 2016-2028 (US$ Bn)
8.4.2.4. Canada Vaccine Delivery Devices, By End User, 2016-2028 (US$ Bn)
9.1. Europe Vaccine Delivery Devices Market, by Product Type, 2016-2028(US$ Bn)
9.1.1. Overview
9.1.2. SRC Analysis
9.2. Europe Vaccine Delivery Devices Markets, by Route of Administration, 2016-2028(US$ Bn)
9.2.1. Overview
9.2.2. SRC Analysis
9.3. Europe Vaccine Delivery Devices Markets, by End User, 2016-2028(US$ Bn)
9.3.1. Overview
9.3.2. SRC Analysis
9.4. Europe Vaccine Delivery Devices Market, by Country, 2016-2028 (US$ Bn)
9.4.1. Germany
9.4.1.1. Germany Vaccine Delivery Devices Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.1.2. Germany Vaccine Delivery Devices, By Product Type, 2016-2028 (US$ Bn)
9.4.1.3. Germany Vaccine Delivery Devices, By Route of Administration, 2016-2028 (US$ Bn)
9.4.1.4. Germany Vaccine Delivery Devices, By End User, 2016-2028 (US$ Bn)
9.4.2. France
9.4.2.1. France Vaccine Delivery Devices Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.2.2. France Vaccine Delivery Devices, By Product Type, 2016-2028 (US$ Bn)
9.4.2.3. France Vaccine Delivery Devices, By Route of Administration, 2016-2028 (US$ Bn)
9.4.2.4. France Vaccine Delivery Devices, By End User, 2016-2028 (US$ Bn)
9.4.3. UK
9.4.3.1. UK Vaccine Delivery Devices Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.3.2. UK Vaccine Delivery Devices, By Product Type, 2016-2028 (US$ Bn)
9.4.3.3. UK Vaccine Delivery Devices, By Route of Administration, 2016-2028 (US$ Bn)
9.4.3.4. UK Vaccine Delivery Devices, By End User, 2016-2028 (US$ Bn)
9.4.4. Italy
9.4.4.1. Italy Vaccine Delivery Devices Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.4.2. Italy Vaccine Delivery Devices, By Product Type, 2016-2028 (US$ Bn)
9.4.4.3. Italy Vaccine Delivery Devices, By Route of Administration, 2016-2028 (US$ Bn)
9.4.4.4. Italy Vaccine Delivery Devices, By End User, 2016-2028 (US$ Bn)
9.4.5. Spain
9.4.5.1. Spain Vaccine Delivery Devices Markets Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.5.2. Spain Vaccine Delivery Devices, By Product Type, 2016-2028 (US$ Bn)
9.4.5.3. Spain Vaccine Delivery Devices, By Route of Administration, 2016-2028 (US$ Bn)
9.4.5.4. Spain Vaccine Delivery Devices, By End User, 2016-2028 (US$ Bn)
9.4.6. Rest of Europe
9.4.6.1. Rest of Europe Vaccine Delivery Devices Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.6.2. Rest of Europe Vaccine Delivery Devices, By Product Type, 2016-2028 (US$ Bn)
9.4.6.3. Rest of Europe Vaccine Delivery Devices, By Route of Administration, 2016-2028 (US$ Bn)
9.4.6.4. Rest of Europe Vaccine Delivery Devices, By End User, 2016-2028 (US$ Bn)
……….
12.1. Middle East and Africa Vaccine Delivery Devices Market, by Product Type, 2016-2028 (US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Middle East and Africa Vaccine Delivery Devices Market, by Route of Administration, 2016-2028(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Middle East and Africa Vaccine Delivery Devices Market, by End User, 2016-2028 (US$ Bn)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. Middle East and Africa Vaccine Delivery Devices Market, by Country, 2016-2028 (US$ Bn)
12.4.1. GCC Countries
12.4.1.1. GCC Countries Vaccine Delivery Devices Market Estimates and Forecast, 2016-2028 (US$ Bn)
12.4.1.2. GCC Countries Vaccine Delivery Devices, By Product Type, 2016-2028 (US$ Bn)
12.4.1.3. GCC Countries Vaccine Delivery Devices, By Route of Administration, 2016-2028 (US$ Bn)
12.4.1.4. GCC Countries Vaccine Delivery Devices, By End User, 2016-2028 (US$ Bn)
12.4.2. South Africa
12.4.2.1. South Africa Vaccine Delivery Devices Market Estimates and Forecast, 2016-2028 (US$ Bn)
12.4.2.2. South Africa Vaccine Delivery Devices, By Product Type, 2016-2028 (US$ Bn)
12.4.2.3. South Africa Vaccine Delivery Devices, By Route of Administration, 2016-2028 (US$ Bn)
12.4.2.4. South Africa Vaccine Delivery Devices, By End User, 2016-2028 (US$ Bn)
12.4.3. Rest of Middle East and Africa
12.4.3.1. Rest of Middle East and Africa Vaccine Delivery Devices Market Estimates and Forecast, 2016-2028 (US$ Bn)
12.4.3.2. Rest of Middle East and Africa Vaccine Delivery Devices, By Product Type, 2016-2028 (US$ Bn)
12.4.3.3. Rest of Middle East and Africa Vaccine Delivery Devices, By Route of Administration, 2016-2028 (US$ Bn)
12.4.3.4. Rest of Middle East and Africa Vaccine Delivery Devices, By End User, 2016-2028 (US$ Bn)
13.1. Panacea Pharmaceuticals
13.1.1. Company Overview
13.1.2. Products/Services Portfolio
13.1.3. Geographical Presence
13.1.4. Financial Summary
13.1.4.1. Market Revenue and Net Profit (2019-2021)
13.1.4.2. Business Segment Revenue Analysis
13.1.4.3. Geographical Revenue Analysis
13.2. 3 M
13.3. Bioject Medical Technologies
13.4. PharmaJet
13.5. Valeritas
13.6. Vaxxas
13.7. Gerresheimer
13.8. Schott AG
13.9. Corium International
13.10. Becton Dickinson & Company
13.11. Others
About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, nonlegislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Top Selling Reports @
mRNA Vaccine and Therapeutics Market by Vaccine Type (Self-amplifying mRNA-based Vaccines, Conventional Non-Amplifying mRNA-Based Vaccines) by Application (Cancer, Infectious Disease, Others) by End User (Hospitals and Clinics, Research Organizations, Other): Growth, Future Prospects & Competitive Analysis, 2015 – 2027
Pneumococcal Vaccines Market By Vaccine Type (Pneumococcal Conjugate Vaccine, Pneumococcal Polysaccharide Vaccine), By Product Type (10-Valent PCV, 13-valent PCV, 23-valent PPSV) – Growth, Future Prospects & Competitive Analysis, 2018 – 2026
Media ContactCompany Name: Credence ResearchContact Person: Chris SmithEmail: Send EmailPhone: 18003618290City: SAN JOSEState: CACountry: United StatesWebsite: https://www.credenceresearch.com/